http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2007116960-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
filingDate | 2007-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2009-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2007116960-A1 |
titleOfInvention | Oxazolidinone derivatives having carbocyclic rings |
abstract | The present invention provides a novel oxazolidinone derivative represented by the formula (I) and an antibacterial agent containing the same. [Ring A is at least a 7-membered monocyclic carbocyclic ring which may be substituted or condensed; X 1 is —O—, —S—, —NR 2 —, —CO—, —CS Selected from the group consisting of —, —CONR 3 —, —NR 4 CO—, —SO 2 NR 5 —, and —NR 6 SO 2 — (R 2 to R 6 are independently hydrogen, lower alkyl, or lower alkoxycarbonyl). Or a lower alkylene or lower alkenylene which may be interposed by the heteroatom-containing group, B ring is an optionally substituted carbocyclic or heterocyclic ring; R1 is hydrogen or an oxazolidinone ring of an oxazolidinone antibacterial agent An organic residue which can be bonded to the 5-position (except when X 1 is —CH 2 O— and R 1 is optionally substituted hydroxymethylene). |
priorityDate | 2006-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 273.